Most Read Articles
3 days ago
Combining the DASH (Dietary Approaches to Stop Hypertension) diet with low sodium intake reduces systolic blood pressure (SBP) in individuals with pre- and stage 1 hypertension, with progressively higher reductions at greater levels of baseline SBP, a recent study has shown.
5 days ago
Cognitive deficits in bipolar disorder are neurodevelopmental rather than neurodegenerative in nature, a recent study has reported. Furthermore, cognitive impairment in bipolar patients appears to be stable, in the majority at least.
2 days ago
Tadalafil may not be effective for reducing the decline in ambulatory ability in boys with Duchenne muscular dystrophy (DMD), as shown in a recent study.
5 days ago
Hydrochlorothiazide (HCTZ) appears to significantly increase the risks of nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), a recent study has shown.

What is the best route of PPI delivery in ANVGIB?

22 Aug 2017

The efficacy of scheduled intravenous (IV) proton pump inhibitors (PPIs) are comparable to that of IV PPI drip for most outcomes in acute nonvariceal upper gastrointestinal bleeding (ANVGIB), a recent systematic review and meta-analysis has found. Moreover, oral PPIs are as effective as scheduled IV for length of stay (LOS) and total units of blood transfused (UBT) and superior to IV PPI drip for risk of surgery (ROS).

Researchers identified a total of 39 studies evaluating acid suppressive medications (IV PPI drip, scheduled IV PPI, oral PPI, H2-receptor antagonists and placebo) in ANVGIB for the following endpoints: risk of rebleeding, LOS, ROS, mortality and total UBT.

Network meta-analysis and Bayesian Markov Chain Monte Carlo methods were used for indirect comparisons and for calculation of probability superiority, respectively.

There was no difference between IV PPI drip and scheduled IV PPI for mortality (relative risk [RR], 1.11; 95 percent credibility interval, 0.56 to 2.21), LOS (RR, 0.04; ‒0.49 to 0.44), ROS (RR, 1.27; 0.64 to 2.35) and risk of rebleeding within 72 hours (RR, 0.98; 0.48 to 1.95), 1 week (RR, 0.59; 0.13 to 2.03) and 1 month (RR, 0.82; 0.28 to 2.16).

In addition, oral PPIs are comparable to schedule IV PPIs and IV PPI drip for LOS (RR, 0.22; ‒0.61 to 0.79 and 0.16; ‒0.56 to 0.80) and UBT (RR, ‒0.25; ‒1.23 to 0.65 and ‒0.06; ‒0.71 to 0.65) and superior to IV PPI drip for ROS (RR, 0.30; 0.10 to 0.78).

“Conclusions should be tempered by low frequency endpoints such as ROS, but question the need for IV PPI drip in ANVGIB,” researchers said.

IV PPIs are the standard medical treatment in ANVGIB, they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
3 days ago
Combining the DASH (Dietary Approaches to Stop Hypertension) diet with low sodium intake reduces systolic blood pressure (SBP) in individuals with pre- and stage 1 hypertension, with progressively higher reductions at greater levels of baseline SBP, a recent study has shown.
5 days ago
Cognitive deficits in bipolar disorder are neurodevelopmental rather than neurodegenerative in nature, a recent study has reported. Furthermore, cognitive impairment in bipolar patients appears to be stable, in the majority at least.
2 days ago
Tadalafil may not be effective for reducing the decline in ambulatory ability in boys with Duchenne muscular dystrophy (DMD), as shown in a recent study.
5 days ago
Hydrochlorothiazide (HCTZ) appears to significantly increase the risks of nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), a recent study has shown.